Volume 21, Issue 2

Volume 21, Issue 2
1-10 of 16 results
1 2

Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation

Mar 24, 2020 by
Nauman Khalid, Hasan Javed, Sarah Aftab Ahmad, J. James Edelman, Evan Shlofmitz, Yuefeng Chen, Anees Musallam, Toby Rogers, Hayder Hashim, Nelson L. Bernardo and Ron Waksman

Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database for Patient- and Circuit-Related Adverse Events Involving Extracorporeal Membrane Oxygenation

Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

Mar 24, 2020 by
Essa Hariri, Darleen Lessard, Joel Gore, Jeffrey Rade and Robert Goldberg

Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

Balloon-expandable transcatheter aortic valve replacement outcomes by procedure location: Catheterization laboratory versus operating room

Mar 24, 2020 by
Tom C. Nguyen, Patricia Keegan, Stephanie Nguyen, Pranav Loyalka, Tsuyoshi Kaneko, Pinak B. Shah, Kendra J. Grubb and Vasilis C. Babaliaros

Balloon-expandable transcatheter aortic valve replacement outcomes by procedure location: Catheterization laboratory versus operating room

Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis

Mar 24, 2020 by
Paul Ndunda, Mohinder R. Vindhyal, Tabitha Muutu and Zaher Fanari

Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis

Editorial: Misclassification of Type 2 Myocardial Infarction: Implications for Value-Based Programs and Quality Metrics

Mar 24, 2020 by
Jason H. Wasfy and Sean P. Murphy

Editorial: Misclassification of Type 2 Myocardial Infarction: Implications for Value-Based Programs and Quality Metrics

Editorial: Transradial Access – to the Heart of the Matter and More

Mar 24, 2020 by
Ronald P. Caputo

Editorial: Transradial Access – to the Heart of the Matter and More

Implications of Misclassification of Type 2 Myocardial Infarction on Clinical Outcomes

Mar 24, 2020 by
Amer Hawatmeh, Mohammad Thawabi, Rashmi Aggarwal, Chandra Abirami, Ilan Vavilin, Najam Wasty, Gautam Visveswaran and Marc Cohen

Implications of Misclassification of Type 2 Myocardial Infarction on Clinical Outcomes

Integrated Stent Delivery System: A Next Generation of Stent Delivery and Drug-Eluting Stent

Mar 24, 2020 by
Tim A. Fischell, Abilash Balmuri, Sourabh Agarwal and Stefan Verhye

Integrated Stent Delivery System: A Next Generation of Stent Delivery and Drug-Eluting Stent

Interventions for Secondary Mitral Regurgitation in Patients With Heart Failure: A Network Meta-Analysis of Randomized Controlled Comparisons of Surgery, Medical Therapy and Transcatheter Intervention

Mar 24, 2020 by
Babikir Kheiri, Yazan Zayed, Mahmoud Barbarawi, Mohammed Osman, Adam Chahine, Sahar Ahmed, Ghassan Bachuwa, Mustafa Hassan, Mohamad Alkhouli, Ted Feldman and Deepak L. Bhatt

Interventions for Secondary Mitral Regurgitation in Patients With Heart Failure: A Network Meta-Analysis of Randomized Controlled Comparisons of Surgery, Medical Therapy and Transcatheter Intervention

Orbital Atherectomy for the Treatment of Long (≥25–40 mm) Severely Calcified Coronary Lesions: ORBIT II Sub-Analysis

Mar 24, 2020 by
Gautam Kumar, Eric Youngyoon Shin, Rajesh Sachdeva, Evan Shlofmitz, Ann N. Behrens, Brad J. Martinsen and Jeffrey W. Chambers

Orbital Atherectomy for the Treatment of Long (≥25–40 mm) Severely Calcified Coronary Lesions: ORBIT II Sub-Analysisv

1-10 of 16 results
1 2

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details